189 results
Page 3 of 10
6-K
EX-99.1
1342c6l q735add3v0xp
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.3
ac5xq
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.1
5pcpl9q
29 Mar 22
RepliCel Announces Non-brokered Private Placement
1:02pm
6-K
EX-99.1
2ptdh9fd7x4ak
29 Mar 22
RepliCel Announces Material Patent Milestones
12:51pm
6-K
EX-99.2
exulr2242nl8btnp
21 Dec 21
51-102F3 Material Change Report
5:28pm
6-K
EX-99.3
doe6u1lr7tl
21 Dec 21
51-102F3 Material Change Report
5:28pm
6-K
EX-99.2
0gkfdop69
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
sf534fs3xz xam4ju
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.2
oir6c
16 Nov 21
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team
4:03pm
6-K
EX-99.1
hrx n72afu6jjf0
16 Nov 21
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team
4:03pm
6-K
EX-99.1
aow097f81e5i g2
2 Nov 21
RepliCel Announces Dermal Injector Update
12:31pm
6-K
EX-99.3
rtzb 8nil3
2 Nov 21
RepliCel Announces Dermal Injector Update
12:31pm
6-K
EX-99.2
pstnbtl ol8
2 Nov 21
RepliCel Announces Dermal Injector Update
12:31pm
6-K
EX-99.1
u9pxup17mi
21 Oct 21
Current report (foreign)
3:49pm
6-K
EX-99.1
5bv1us zm
14 Oct 21
51-102F3 Material Change Report
4:00pm
6-K
EX-99.1
3epkm bd8ejsxu
13 Oct 21
RepliCel Life Sciences Appoints One of Japan’s Foremost Regenerative Medicine Industry Business Leaders as Strategic Advisor
12:00am
6-K
EX-99.1
lu3r56qh9
12 Oct 21
RepliCel and University of Victoria Collaboration Leads to Bioengineering Innovations, Funding, and Patents
1:06pm
6-K
EX-99.1
e8c8ue87l 6ilmv8
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
vrr2mfkgek1hu3jh
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.1
hcr e4p4o2evx5w
18 Aug 21
RepliCel Applies for Manufacturing Approval for its Collagen and Tissue Regeneration Cell Therapies
12:38pm